• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质代谢重编程在肿瘤微环境中的作用。

The role of lipid metabolic reprogramming in tumor microenvironment.

机构信息

Department of Thoracic Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, 214023, China.

Department of Oncology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing, 210029, China.

出版信息

Theranostics. 2023 Mar 13;13(6):1774-1808. doi: 10.7150/thno.82920. eCollection 2023.

DOI:10.7150/thno.82920
PMID:37064872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10091885/
Abstract

Metabolic reprogramming is one of the most important hallmarks of malignant tumors. Specifically, lipid metabolic reprogramming has marked impacts on cancer progression and therapeutic response by remodeling the tumor microenvironment (TME). In the past few decades, immunotherapy has revolutionized the treatment landscape for advanced cancers. Lipid metabolic reprogramming plays pivotal role in regulating the immune microenvironment and response to cancer immunotherapy. Here, we systematically reviewed the characteristics, mechanism, and role of lipid metabolic reprogramming in tumor and immune cells in the TME, appraised the effects of various cell death modes (specifically ferroptosis) on lipid metabolism, and summarized the antitumor therapies targeting lipid metabolism. Overall, lipid metabolic reprogramming has profound effects on cancer immunotherapy by regulating the immune microenvironment; therefore, targeting lipid metabolic reprogramming may lead to the development of innovative clinical applications including sensitizing immunotherapy.

摘要

代谢重编程是恶性肿瘤的重要标志之一。具体而言,脂质代谢重编程通过重塑肿瘤微环境(TME),对癌症进展和治疗反应产生显著影响。在过去的几十年中,免疫疗法彻底改变了晚期癌症的治疗格局。脂质代谢重编程在调节免疫微环境和对癌症免疫疗法的反应中起着关键作用。在这里,我们系统地综述了脂质代谢重编程在 TME 中的肿瘤和免疫细胞中的特征、机制和作用,评估了各种细胞死亡模式(特别是铁死亡)对脂质代谢的影响,并总结了针对脂质代谢的抗肿瘤治疗方法。总的来说,脂质代谢重编程通过调节免疫微环境对癌症免疫疗法有深远影响;因此,靶向脂质代谢重编程可能会导致创新的临床应用的发展,包括增强免疫疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7249/10091885/07b6540746da/thnov13p1774g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7249/10091885/93b4c7ca1ce2/thnov13p1774g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7249/10091885/b6b3769068cb/thnov13p1774g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7249/10091885/f0a0b4d135bd/thnov13p1774g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7249/10091885/07b6540746da/thnov13p1774g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7249/10091885/93b4c7ca1ce2/thnov13p1774g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7249/10091885/b6b3769068cb/thnov13p1774g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7249/10091885/f0a0b4d135bd/thnov13p1774g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7249/10091885/07b6540746da/thnov13p1774g004.jpg

相似文献

1
The role of lipid metabolic reprogramming in tumor microenvironment.脂质代谢重编程在肿瘤微环境中的作用。
Theranostics. 2023 Mar 13;13(6):1774-1808. doi: 10.7150/thno.82920. eCollection 2023.
2
Biomaterial-Mediated Metabolic Regulation of Ferroptosis for Cancer Immunotherapy.生物材料介导的铁死亡代谢调控在癌症免疫治疗中的作用
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Nov-Dec;16(6):e2010. doi: 10.1002/wnan.2010.
3
Unraveling the role of GPCR signaling in metabolic reprogramming and immune microenvironment of lung adenocarcinoma: a multi-omics study with experimental validation.揭示GPCR信号在肺腺癌代谢重编程和免疫微环境中的作用:一项具有实验验证的多组学研究
Front Immunol. 2025 Jun 6;16:1606125. doi: 10.3389/fimmu.2025.1606125. eCollection 2025.
4
Interplay between the complement system and other immune pathways in the tumor microenvironment.肿瘤微环境中补体系统与其他免疫途径之间的相互作用。
Semin Immunol. 2025 Jun;78:101951. doi: 10.1016/j.smim.2025.101951. Epub 2025 Apr 9.
5
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
6
Tumor-derived CD109 orchestrates reprogramming of tumor-associated macrophages to dampen immune response.肿瘤来源的CD109协调肿瘤相关巨噬细胞的重编程以抑制免疫反应。
J Hepatol. 2025 Apr 11. doi: 10.1016/j.jhep.2025.03.035.
7
Cancer cell-derived extracellular vesicles: a potential target for overcoming tumor immunotherapy resistance and immune evasion strategies.癌细胞衍生的细胞外囊泡:克服肿瘤免疫治疗耐药性和免疫逃逸策略的潜在靶点。
Front Immunol. 2025 Jun 12;16:1601266. doi: 10.3389/fimmu.2025.1601266. eCollection 2025.
8
Dietary impacts on prostate cancer immunotherapy.饮食对前列腺癌免疫治疗的影响。
Immunotherapy. 2025 May;17(7):525-536. doi: 10.1080/1750743X.2025.2511472. Epub 2025 May 29.
9
STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer.STING 激动剂克服了卵巢癌中 STAT3 介导的免疫抑制和对 PARP 抑制的适应性耐药。
J Immunother Cancer. 2023 Jan;11(1). doi: 10.1136/jitc-2022-005627.
10
Pathway-based cancer transcriptome deciphers a high-resolution intrinsic heterogeneity within bladder cancer classification.基于通路的癌症转录组解析膀胱癌分类中的高分辨率内在异质性。
J Transl Med. 2025 Jun 17;23(1):666. doi: 10.1186/s12967-025-06682-1.

引用本文的文献

1
FASN promotes the stemness of cancer stem cells and protects colorectal cancer cells from ferroptosis by inhibiting the activation of SREBP2.脂肪酸合酶(FASN)通过抑制固醇调节元件结合蛋白2(SREBP2)的激活来促进癌症干细胞的干性,并保护结肠直肠癌细胞免受铁死亡。
Front Immunol. 2025 Aug 18;16:1611375. doi: 10.3389/fimmu.2025.1611375. eCollection 2025.
2
Protein lipoylation in cancer: metabolic reprogramming and therapeutic potential.癌症中的蛋白质脂酰化:代谢重编程与治疗潜力
Cell Death Discov. 2025 Sep 2;11(1):420. doi: 10.1038/s41420-025-02718-z.
3
NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation.

本文引用的文献

1
Fatty acid transport proteins (FATPs) in cancer.癌症中的脂肪酸转运蛋白(FATPs)
Chem Phys Lipids. 2023 Jan;250:105269. doi: 10.1016/j.chemphyslip.2022.105269. Epub 2022 Nov 30.
2
Copper homeostasis and cuproptosis in health and disease.铜稳态和铜死亡在健康和疾病中的作用。
Signal Transduct Target Ther. 2022 Nov 23;7(1):378. doi: 10.1038/s41392-022-01229-y.
3
Liver tumour immune microenvironment subtypes and neutrophil heterogeneity.肝肿瘤免疫微环境亚型与中性粒细胞异质性
NeuroD1驱动KAT2A-FDFT1信号轴,通过组蛋白H3K27乙酰化促进胆固醇生物合成和肝细胞癌进展。
Oncogene. 2025 Sep 1. doi: 10.1038/s41388-025-03534-6.
4
Lipid metabolites as biomarkers and therapeutic targets in oral squamous cell carcinoma.脂质代谢产物作为口腔鳞状细胞癌的生物标志物和治疗靶点
BMC Oral Health. 2025 Aug 31;25(1):1390. doi: 10.1186/s12903-025-06700-0.
5
Lipid homeostasis dysregulation in oral cancer drives metabolic reprogramming and offers novel diagnostic and therapeutic opportunities.口腔癌中的脂质稳态失调驱动代谢重编程,并提供了新的诊断和治疗机会。
Discov Oncol. 2025 Aug 25;16(1):1613. doi: 10.1007/s12672-025-03299-0.
6
IGF2BP1-mediated methylation of ABCA1 facilitates tumor progression by affecting cholesterol metabolism in lung adenocarcinoma.IGF2BP1介导的ABCA1甲基化通过影响肺腺癌中的胆固醇代谢促进肿瘤进展。
Amino Acids. 2025 Aug 22;57(1):42. doi: 10.1007/s00726-025-03474-1.
7
High oxidative phosphorylation represented by UQCRFS1 marks CD8 + tumor-infiltrating lymphocytes exhaustion in diffuse large B-cell lymphoma.由UQCRFS1所代表的高氧化磷酸化标志着弥漫性大B细胞淋巴瘤中CD8 +肿瘤浸润淋巴细胞的耗竭。
Biol Direct. 2025 Aug 13;20(1):92. doi: 10.1186/s13062-025-00684-1.
8
DHCR24 overexpression is involved in lipid metabolic reprogramming to drive cervical cancer malignant progression and is associated with immune microenvironment.DHCR24过表达参与脂质代谢重编程以驱动宫颈癌恶性进展,并与免疫微环境相关。
BMC Cancer. 2025 Aug 9;25(1):1291. doi: 10.1186/s12885-025-14663-2.
9
Mitochondrial metabolic reprogramming in colorectal cancer: mechanisms of resistance and future clinical interventions.结直肠癌中的线粒体代谢重编程:耐药机制与未来临床干预措施
Cell Death Discov. 2025 Aug 9;11(1):375. doi: 10.1038/s41420-025-02670-y.
10
CCT196969 inhibits TNBC by targeting the HDAC5/RXRA/ASNS axis to down-regulate asparagine synthesis.CCT196969通过靶向HDAC5/RXRA/ASNS轴来下调天冬酰胺合成,从而抑制三阴性乳腺癌。
J Exp Clin Cancer Res. 2025 Aug 8;44(1):231. doi: 10.1186/s13046-025-03494-5.
Nature. 2022 Dec;612(7938):141-147. doi: 10.1038/s41586-022-05400-x. Epub 2022 Nov 9.
4
Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy.三阴性乳腺癌中的铁死亡异质性揭示了一种创新的免疫治疗联合策略。
Cell Metab. 2023 Jan 3;35(1):84-100.e8. doi: 10.1016/j.cmet.2022.09.021. Epub 2022 Oct 17.
5
Targeted inhibition of tumor-derived exosomes as a novel therapeutic option for cancer.靶向肿瘤来源的外泌体抑制作为一种癌症治疗的新选择。
Exp Mol Med. 2022 Sep;54(9):1379-1389. doi: 10.1038/s12276-022-00856-3. Epub 2022 Sep 18.
6
Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity.乳酸增加 CD8+T 细胞的干性以增强抗肿瘤免疫。
Nat Commun. 2022 Sep 6;13(1):4981. doi: 10.1038/s41467-022-32521-8.
7
Identification of cuproptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer.识别铜死亡相关亚型,剖析肿瘤微环境浸润,建立乳腺癌预后模型。
Front Immunol. 2022 Aug 19;13:996836. doi: 10.3389/fimmu.2022.996836. eCollection 2022.
8
Discovery of a mammalian FASN inhibitor against xenografts of non-small cell lung cancer and melanoma.一种针对非小细胞肺癌和黑色素瘤异种移植的哺乳动物脂肪酸合酶(FASN)抑制剂的发现。
Signal Transduct Target Ther. 2022 Aug 24;7(1):273. doi: 10.1038/s41392-022-01099-4.
9
Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer.铜死亡评分系统预测膀胱癌的临床结局和免疫反应。
Front Immunol. 2022 Aug 4;13:958368. doi: 10.3389/fimmu.2022.958368. eCollection 2022.
10
The emerging role of 27-hydroxycholesterol in cancer development and progression: An update.27-羟胆固醇在癌症发展和进展中的新作用:最新研究进展。
Int Immunopharmacol. 2022 Sep;110:109074. doi: 10.1016/j.intimp.2022.109074. Epub 2022 Jul 21.